Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BW.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.312NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.13.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.220NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.142NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.523NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.36.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.418NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.389NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.53NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.363NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HV.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.405NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.282NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.228NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.174NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.88 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.106 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.346NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.93NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.39NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.40NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.3.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.57NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EF.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.32NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BW.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CK.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.8.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CA.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.61NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ED.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BU.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.3.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XCGNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.30NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DT.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DT.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XCANChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.50NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.54NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GN.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.77 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used